Page 1, line 2, strike "July" insert "the later of October"; after the last quotation
marks insert “; after "2017"
insert "or sixty days after the
statewide health information exchange has integrated the controlled substances
prescription monitoring program data into the exchange"”
Line 3, after the comma insert "after "system" insert "at the beginning of each new course of
treatment and at least quarterly while that prescription remains a part of the
treatment""; strike "The" insert "Each medical practitioner regulatory board shall notify the
medical practitioners licensed by that board of the applicable date. A"
Line 4, strike "six‑month"
insert "one‑year"
Line 7, strike "board";
after "rule"
insert "by the Arizona state board
of pharmacy"
Between lines 10 and 11, insert:
"Line 25, after "care" insert "or palliative care for a serious or chronic illness""
Strike line 16, insert:
"Strike line 34, insert "than a ten‑day period for an invasive medical or
dental procedure or a medical or dental procedure that results in acute pain to
the patient.""
Line 22, after the period insert a quotation mark
Strike lines 23 and 24
Page 2, strike lines 1 and 2, insert:
"Line 44, after "faith" insert ", or the medical practitioner's employer,""
Page 4, between lines 13 and 14,
insert:
"Sec. 3. Controlled substances prescription monitoring program;
analysis; report; delayed repeal
A. The Arizona state board of pharmacy shall
contract with a third party to conduct an analysis of the controlled substances
prescription monitoring program and report on at least the following:
1. The usability and length of time to query data on
the controlled substances prescription monitoring program's central database
tracking system and recommendations to improve system properties for more
efficient and effective clinical use by medical practitioners.
2. Strategies to increase and promote use by medical
practitioners.
3. The quality of the data and recommendations to
improve accuracy and validity.
4. Strategies to make it easier to integrate the
controlled substances prescription monitoring program's central database into
electronic health records.
5. An analysis of available and necessary resources
for the Arizona state board of pharmacy to implement the requirements of
section 32‑2606, Arizona Revised Statutes, as amended by this act.
6. Best practices in this state and other states
that have a controlled substances prescription monitoring program or database.
B. The report shall be completed on or before
January 1, 2017. On or before January 15, 2017, the Arizona state board of
pharmacy shall deliver the report to the president of the senate, the speaker
of the house of representatives and the governor and shall provide a copy to
the secretary of state.
C. This section is repealed from and after September
30, 2017.
Sec. 4. Controlled substances prescription monitoring program;
electronic health records; integration; quarterly reports; delayed repeal
A. On or before October 1, 2016 and every quarter
for the following four years, the Arizona state board of pharmacy shall
complete a quarterly report on the number and names of electronic health
records companies that have integrated the controlled substances prescription
monitoring program's central database or are in the process of integrating the
database for use by medical practitioners. The report shall include
the number of medical practitioners who will have access to the integrated data
through an electronic health records system. The board shall post
each report on its public website.
B. This section is repealed from and after September
30, 2021.
Sec. 5. Rulemaking exemption
For the purposes of this act, the Arizona state board of
pharmacy is exempt from the rulemaking requirement of title 41, chapter 6,
Arizona Revised Statutes, for one year after the effective date of this
act."
Amend title to conform
Bill
Number: S.B. 1283